Recombinant human FSH (Gonal-F(R)) versus highly purified urinary FSH (Metrodin HP(R)): results of a randomized comparative study in women undergoing assisted reproductive techniques

被引：0

作者：

Berg, C

Howles, CM

Borg, K

Hamberger, L

Josefsson, B

Nilsson, L

Wikland, M

机构：

[1] GOTHENBURG UNIV,SAHLGRENSKA HOSP,DEPT OBSTET & GYNAECOL,GENEVA,SWITZERLAND

[2] FERTIL CTR SCANDINAVIA,GOTHENBURG,SWEDEN

[3] ARES SERONO,GENEVA,SWITZERLAND

来源：

HUMAN REPRODUCTION | 1997年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：O109 / O109

页数：2

共 40 条

[21] Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
Alberto Revelli
Francesca Poso
Gianluca Gennarelli
Federica Moffa
Giuseppina Grassi
Marco Massobrio
Reproductive Biology and Endocrinology, 4
[22] A Randomized study of recombinant versus urinary human chorionic gonadotrophin in Chinese women undergoing assisted reproductive technology cycles.
Jie, Q
Guijin, Z
Guoning, H
FERTILITY AND STERILITY, 2005, 84 : S301 - S301
[23] Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
Klaus F. Bühler
Robert Fischer
Patrice Verpillat
Arthur Allignol
Sandra Guedes
Emmanuelle Boutmy
Wilma Bilger
Emilia Richter
Thomas D’Hooghe
Reproductive Biology and Endocrinology, 19
[24] Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
Buehler, Klaus F.
Fischer, Robert
Verpillat, Patrice
Allignol, Arthur
Guedes, Sandra
Boutmy, Emmanuelle
Bilger, Wilma
Richter, Emilia
D'Hooghe, Thomas
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
[25] A multicentre, prospective, randomized study to compare a low-dose protocol versus conventional administration of recombinant human follicle stimulating hormone (Gonal-F®) in normo-responder women undergoing IVF/ICSI
Camier, B
Howles, CM
Truong, F
HUMAN REPRODUCTION, 1998, 13 : 159 - 159
[26] An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum β 150 IU and highly purified urinary FSH225IUas a fixed dose regimen in IVF/ICSI treatment
Berger, E
Chabloz, P
De Quay, N
Sann, A
Walton, S
Germond, M
Birkhäuser, M
HUMAN REPRODUCTION, 1999, 14 : 61 - 62
[27] Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-α (Gonal-F®) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology
Moon, Shin Yong
Choi, Young Sik
Ku, Seung-Yup
Kim, Seok Hyun
Choi, Young Min
Kang, Inn Soo
Kim, Chung Hoon
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2007, 33 (03) : 305 - 315
[28] A prospective randomized multicentre study comparing low-dose versus conventional dose GnRH agonist in a long protocol using recombinant human follicle-stimulating hormone (Gonal-F®) in women undergoing an in-vitro fertilization
Hazout, A
Howles, C
Truong, F
HUMAN REPRODUCTION, 1998, 13 : 151 - 151
[29] Comparison of the Recombinant Versus Highly-Purified, Urinary Follicle-Stimulating Hormone (r-FSH vs. HP-uFSH) in the Polycystic Ovary Syndrom Patients who had Antagonist Cycle with In Vitro Fertilization-Embryo Transfer
Kara, Mustafa
Kutlu, Tayfun
Sofuoglu, Kenan
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (04): : 775 - 779
[30] A phase III assessor-blinded randomised multi-centre study to compare efficacy and safety of two r-hFSH formulations (AFOLIA [Bemfola®] vs Gonal-f®) in women for assisted reproductive treatment
Imthurn, B.
Rettenbacher, M.
HUMAN REPRODUCTION, 2013, 28 : 45 - 45

← 1 2 3 4 →